Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens

To evaluate visual outcomes and quality of vision following bilateral implantation of a hydrophobic acrylic intraocular lens (IOL) in eyes targeted for emmetropia.

This was a prospective, single arm study. Subjects were bilaterally implanted with the Clareon PanOptix IOL and evaluated at 1 and 3 months postoperatively. Endpoints included binocular uncorrected and distance-corrected visual acuities at distance (UDVA, CDVA), intermediate (UIVA, DCIVA; 60 cm), and near (UNVA, DCNVA; 40 cm, 33 cm), defocus curve, manifest refraction, and administration of a visual disturbance questionnaire (QUVID) and a satisfaction questionnaire (IOLSAT).

A total of 24 subjects (48 eyes) completed the study. Mean postoperative binocular CDVA, DCIVA (60 cm), DCNVA (40 cm), and DCNVA (33 cm) were -0.04 ± 0.08 logMAR, -0.08 ± 0.10 logMAR, 0.01 ± 0.10 logMAR, and 0.04 ± 0.11 logMAR, respectively. Mean postoperative binocular UDVA, UIVA (60 cm), UNVA (40 cm), and UNVA (33 cm) were 0.02 ± 0.19 logMAR, -0.08 ± 0.09 logMAR, 0.04 ± 0.12 logMAR, and 0.08 ± 0.15 logMAR, respectively. Overall, postoperative spectacle independence at distance, intermediate, and near were 100%, 93%, and 73%, respectively. A total of 9%, 12%, and 0% of subjects were bothered "quite a bit" or "very much" by halos, starburst, and glare, respectively.

The results of this study suggest that bilateral implantation with the Clareon PanOptix can achieve excellent visual outcomes, high spectacle independence, and low reports of bothersome dysphotopsia.